Understanding teh Link ⁢Between Narcolepsy ‌and‍ cardiovascular Disease

People with narcolepsy have a 2-to-3-fold higher risk of cardiovascular​ disease ​compared ‍to ‌those without the condition, according to recent findings. This increased risk underscores the need for heightened awareness and‍ preventative measures within the patient⁣ population. This ⁤risk is often linked⁣ to factors⁢ beyond ⁣the core symptoms of narcolepsy, including lifestyle and dietary habits.

The Role‌ of ‌Sodium Intake

Sodium intake is a⁢ well-established contributor to cardiovascular risk, and ‌reducing it can be a “fixable problem” for narcolepsy ‍patients, as highlighted ​by Dr. Kovacs in a recent interview with Pharmacy Times. ​High sodium levels contribute to hypertension, a major risk factor for heart⁢ disease and stroke. Addressing sodium intake is a practical and impactful step towards mitigating cardiovascular risks ⁤in this vulnerable population.

While specific data on sodium ‍intake levels​ in narcolepsy patients is limited,general ⁢dietary guidelines recommend limiting sodium intake to less than 2,300 milligrams ‍per‌ day. Many​ processed foods and restaurant meals significantly exceed this recommendation.

Pharmacists as Frontline Educators

Pharmacists are uniquely positioned to play a vital role in⁤ identifying⁣ and counseling patients who ‌could‍ benefit from reducing their sodium intake, particularly when considering medications like oxybate. They can review patient medication lists, assess ‌dietary habits, and provide tailored recommendations for low-sodium alternatives.

Specifically, pharmacists can:

• identify at-risk ⁢patients: ⁣Recognize individuals with narcolepsy and proactively assess their cardiovascular risk factors.
• Counsel on ​low-sodium diets: Provide practical advice‌ on reading food labels, choosing low-sodium options,⁣ and ⁢preparing meals with less salt.
• Discuss low-sodium oxybate: Inform patients about the availability‌ of low-sodium oxybate formulations and their potential benefits.
• Monitor medication interactions: Ensure that any dietary changes or medication adjustments do not negatively interact with other treatments.

Low-Sodium Oxybate: A Potential Solution

Xywav (sodium​ oxybate) is a medication used to ⁢treat excessive daytime sleepiness and cataplexy associated with narcolepsy. Customary oxybate formulations‌ contain notable amounts of sodium. The availability of low-sodium ‌oxybate formulations offers a⁢ valuable tool ⁤for managing both narcolepsy symptoms and cardiovascular risk.

The difference in sodium​ content between‌ standard and low-sodium oxybate can be substantial. For example,a typical dose of standard oxybate may contain ​over 700mg of sodium,while a comparable dose of low-sodium oxybate may⁤ contain less than 100mg. This reduction ​can be particularly beneficial for patients with pre-existing​ hypertension or other cardiovascular conditions.